Kishor M. Wasan
Affiliations: | Pharmaceutical Sciences | University of Saskatchewan, Saskatoon, SK, Canada |
Google:
"Kishor Wasan"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Høtoft Michaelsen M, Siqueira Jørgensen SD, Mahad Abdi I, et al. (2019) Fenofibrate oral absorption from SNEDDS and super-SNEDDS is not significantly affected by lipase inhibition in rats. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V |
| Gordon JA, Noble JW, Midha A, et al. (2019) Upregulation of Scavenger receptor B1 is required for steroidogenic and non-steroidogenic cholesterol metabolism in prostate cancer. Cancer Research |
| Sassene PJ, Michaelsen MH, Mosgaard MD, et al. (2016) In vivo precipitation of poorly soluble drugs from lipid based drug delivery systems. Molecular Pharmaceutics |
| Wasan KM, Goss PE, Pritchard PH, et al. (2012) Lipid concentrations in postmenopausal women on letrozole after 5 years of tamoxifen: an NCIC CTG MA.17 sub-study. Breast Cancer Research and Treatment. 136: 769-76 |
| Lee SD, Gershkovich P, Darlington JW, et al. (2012) Inhibition of cholesterol absorption: targeting the intestine. Pharmaceutical Research. 29: 3235-50 |
| Zhao J, Gershkovich P, Wasan KM. (2012) Evaluation of the effect of plant sterols on the intestinal processing of cholesterol using an in vitro lipolysis model. International Journal of Pharmaceutics. 436: 707-10 |
| Aikawa N, Okubo Y, Lynn M, et al. (2012) Safety, pharmacokinetics and pharmacodynamics of four-hour intravenous infusions of eritoran in healthy Japanese and Caucasian men. Innate Immunity. 18: 793-803 |
| Gershkovich P, Sivak O, Contreras-Whitney S, et al. (2012) Assessment of cholesterol absorption inhibitors nanostructured aluminosilicate and cholestyramine using in vitro lipolysis model. Journal of Pharmaceutical Sciences. 101: 291-300 |
| Fleischer JG, Rossignol D, Francis GA, et al. (2012) Deactivation of the lipopolysaccharide antagonist eritoran (E5564) by high-density lipoprotein-associated apolipoproteins. Innate Immunity. 18: 171-8 |
| Wasan KM, Cassidy SM, Kennedy AL, et al. (2012) Lipoprotein isolation and analysis from serum by preparative ultracentrifugation. Methods in Molecular Medicine. 52: 27-35 |